| Name | Belluscura |
|---|---|
| Epic | BELL |
| Isin | GB00BD3B8Z11 |
| Industry | Medical Equipment and Services |
| Latest share price | 9.25p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £15.58 | Debt ratio | n/a |
| Shares in issue | 168.41 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -240.37 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -14.2 | 52-week high / low | 7.25p / 25.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Belluscura |
|---|---|
| Address | 15 Fetter Lane, London, United Kingdom, EC4A 1BW |
| Telephone | +44 (0) 7814 229686 |
| Website | https://www.belluscura.com/ |
| Director | Position |
|---|---|
| Mr Robert "Bob" Rauker | CEO |
| Mr Simon Neicheril | CFO |
| Mr David Poutney | Non-Executive Director |
| Mr Robert (Bob) Sylvester Fary | Executive Director |
| Mr Adam Reynolds | Non-Executive Chairman |
| Mr Richard John (Ric) Piper | Independent Non-Executive Director |
| Dr Patrick Strollo | Independent Non-Executive Director |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 9.99 | 8.67 | 0.05 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 12.26 | 9.07 | 7.05 |
| Inventory / work in progress | 3.32 | 8.43 | 0.31 |
| Trade and other receivables | 4.31 | 4.05 | 2.76 |
| Cash and equivalents | 0.93 | 2.04 | 15.89 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 20.82 | 23.6 | 26 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 3.07 | 3.05 | 1.08 |
| Long term liabilities | 0.06 | 0.2 | 0.25 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 3.13 | 3.25 | 1.33 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 17.69 | 20.35 | 24.67 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 1.85 | 1.66 | 1.55 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -28.64 | -10.31 | -2.35 |
| Share premium account | 37.49 | 33.38 | 26.03 |
| Total equity | 17.69 | 20.35 | 24.67 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -17.69 | -8.13 | -5.19 |
| Pre-tax profit | -18.52 | -8.15 | -5.21 |